BUY Krishna Institute of Medical Sciences Limited — Jigar S Patel, Anand Rathi
byJigar S Patel, Anand RathiHorizon: 1–3 months19 Oct 2026via ET Now
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
RSI at 19 — oversold territory
Technicals · rsi·20 Oct · today
4 advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·9 Oct · 2w ago
Krishna Institute of Medical Sciences Ltd will acquire up to 22% equity stake in Splendid Hospitals Private Limited for an aggregate cash consideration of up to Rs 40 crore by way of primary infusion.
BSE · Company Update·6 Oct · 2w ago
Krishna Institute of Medical Sciences Ltd will acquire a 51% equity stake in Sarvottam Health Care Private Limited for up to Rs 80 crore, marking a strategic investment in the Kakinada healthcare mark
BSE · Company Update·6 Oct · 2w ago
Krishna Institute of Medical Sciences Ltd will acquire a 6% stake in Ushahkal Abhinav Specialty Hospital LLP for Rs 15 crore via primary infusion to strengthen its strategic O&M partnership.
BSE · Company Update·6 Oct · 2w ago
MACD below its signal line — bearish momentum
Technicals · macd·20 Oct · today
Hospital stocks fall up to 6%: Apollo, Fortis, KIMS tumble as SC questions drug mark-ups
NewsEt-Markets·30 Sept · 3w ago
Explained - Why Hospital stocks Apollo, Max, Fortis, KIMS are down up to 7% on Wednesday
NewsCnbc-Tv18·30 Sept · 3w ago
Apollo, Max Health, Yatharth, KIMS hospital stocks under pressure after SC remarks on drug prices
NewsHbl·30 Sept · 3w ago
Apollo Hospitals, Max Health, Yatharth Hospital, KIMS, other hospital stocks under pressure as SC remarks on drug prices weigh
NewsHbl·30 Sept · 3w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Krishna Institute of Medical Sciences
- BUY — HSBC Securities9 Oct 2026 · ~1 year · target ₹865 · Active
- BUY — Goldman Sachs1 Oct 2026 · ~1 year · target ₹1,000 · Active
- BUY — Emkay Global1 Oct 2026 · ~1 year · target ₹850 · Active
- BUY — Rakesh Bansal24 Sept 2026 · ~2 weeks · target ₹831 · SL hit
- BUY — IDBI Capital17 Sept 2026 · ~3 months · target ₹846 · SL hit
More from Jigar S Patel, Anand Rathi
- BUY PG Electroplast19 Oct 2026 · ~3 months · target ₹580 · Active
- BUY Wipro19 Oct 2026 · ~2 weeks · target ₹195 · Active
- BUY Grindwell Norton19 Oct 2026 · ~3 months · target ₹2,300 · Active
- BUY Rolex Rings19 Oct 2026 · ~2 weeks · target ₹200 · Active
- BUY Indian Railway Catering And Tourism Corporation19 Oct 2026 · ~1 year · target ₹600 · Active

